Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castrate Resistance Prostate Cancer × Radiosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 118 Carcinoma, Non-Small-Cell Lung 112 Prostatic Neoplasms 101 Neoplasm Metastasis 83 Lung Neoplasms 64 Pancreatic Neoplasms 61 Carcinoma, Hepatocellular 58 Breast Neoplasms 45 Melanoma 43 Carcinoma, Renal Cell 32 Neoplasms 31 Colorectal Neoplasms 24 Glioblastoma 23 Squamous Cell Carcinoma of Head and Neck 19 Liver Neoplasms 16 Head and Neck Neoplasms 14 Small Cell Lung Carcinoma 13 Sarcoma 12 Kidney Neoplasms 12 Glioma 11 Recurrence 9 Urinary Bladder Neoplasms 8 Gliosarcoma 7 Central Nervous System Neoplasms 7 Adenocarcinoma 7 Radiation Injuries 6 Prostate Cancer Metastatic 6 Ovarian Neoplasms 6 Neuroma, Acoustic 6 Meningioma 6

Interventions

Radiosurgery 1 Deamino Arginine Vasopressin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06927635 2025-09-05

SECURE

University Health Network, Toronto

Phase 2 Recruiting

Castrate Resistance Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡